Chemical Company of Malaysia Bhd (CCM):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Chemical Company of Malaysia Bhd (CCM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9943
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:マレーシア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Chemical Company of Malaysia Bhd (CCM) is an industrial and specialty chemicals company. It manufactures and markets chlor-alkali and coagulant products; markets industrial and specialty chemicals; and produces polymer coating. The company’s chemical offerings find application in petrochemicals, oleochemicals, potable drinking water, municipal and industrial water treatment, rubber glove manufacturing and other major industries in Malaysia and the Asean region. Polymer coatings are used in local glove manufacturing and are exported to other glove producing countries such as China, Thailand and Indonesia and China. The company operates subsidiaries in Malaysia, Thailand, Singapore, Indonesia and Philippines. CCM is headquartered in Kuala Lumpur, Malaysia.

Chemical Company of Malaysia Bhd (CCM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Chemical Company of Malaysia Bhd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Chemical Company of Malaysia Bhd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Chemical Company of Malaysia Bhd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Chemical Company of Malaysia Bhd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Chemical Company of Malaysia Bhd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Chemical Company of Malaysia Bhd, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
Chemical Company of Malaysia to Raise USD15.79 Million in Private Placement of Shares 10
Acquisition 11
CCM Duopharma Biotech to Acquire 8.39% Stake in Pangen Biotech from Chemical Company of Malaysia for USD9.4 Million 11
CCM Duopharma Biotech Acquires Six Pharma Units from Chemical Company of Malaysia for USD66.16 Million 13
Chemical Company Of Malaysia Acquires 11.6% Stake In PanGen Biotech 14
Chemical Company of Malaysia Bhd – Key Competitors 15
Chemical Company of Malaysia Bhd – Key Employees 16
Chemical Company of Malaysia Bhd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Chemical Company of Malaysia Bhd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Chemical Company of Malaysia Bhd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Chemical Company of Malaysia Bhd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Chemical Company of Malaysia Bhd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Chemical Company of Malaysia Bhd, Deals By Therapy Area, 2012 to YTD 2018 8
Chemical Company of Malaysia Bhd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Chemical Company of Malaysia to Raise USD15.79 Million in Private Placement of Shares 10
CCM Duopharma Biotech to Acquire 8.39% Stake in Pangen Biotech from Chemical Company of Malaysia for USD9.4 Million 11
CCM Duopharma Biotech Acquires Six Pharma Units from Chemical Company of Malaysia for USD66.16 Million 13
Chemical Company Of Malaysia Acquires 11.6% Stake In PanGen Biotech 14
Chemical Company of Malaysia Bhd, Key Competitors 15
Chemical Company of Malaysia Bhd, Key Employees 16
Chemical Company of Malaysia Bhd, Subsidiaries 17

List of Figures
Chemical Company of Malaysia Bhd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Chemical Company of Malaysia Bhd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Chemical Company of Malaysia Bhd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Chemical Company of Malaysia Bhd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Chemical Company of Malaysia Bhd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Chemical Company of Malaysia Bhd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Chemical Company of Malaysia Bhd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Chemical Company of Malaysia Bhd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Chemical Company of Malaysia Bhd (CCM):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AMETEK Inc (AME):医療機器:M&Aディール及び事業提携情報
    Summary AMETEK Inc (AMETEK) is an electronic products manufacturing company that manufactures electronic instruments and electromechanical devices. The company's products include medical materials, motion control systems, sub assemblies and connectors, electrical cord reels, gauges, titanium alloys …
  • Sonoma Pharmaceuticals Inc (OCLS):企業の財務・戦略的SWOT分析
    Summary Sonoma Pharmaceuticals Inc (Sonoma), formerly Oculus Innovative Sciences, is a pharmaceutical company that develops, manufactures and markets prescription and non-prescription products for the treatment of dermatological conditions and advanced tissue care. The company offers products for ad …
  • Breko GmbH:企業の戦略・SWOT・財務分析
    Breko GmbH - Strategy, SWOT and Corporate Finance Report Summary Breko GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Teleplan International NV:企業の戦略的SWOT分析
    Teleplan International NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • UCB SA (UCB):企業の財務・戦略的SWOT分析
    UCB SA (UCB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Ecclesiastical Insurance Group plc:企業の戦略・SWOT・財務情報
    Ecclesiastical Insurance Group plc - Strategy, SWOT and Corporate Finance Report Summary Ecclesiastical Insurance Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • R. R. Donnelley & Sons Company:企業の戦略・SWOT・財務情報
    R. R. Donnelley & Sons Company - Strategy, SWOT and Corporate Finance Report Summary R. R. Donnelley & Sons Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Isagen SA ESP:企業の戦略的SWOT分析
    Isagen SA ESP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Adept Technology, Inc.:企業の戦略的SWOT分析
    Adept Technology, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • FlightSafety International Inc:企業の戦略・SWOT・財務分析
    FlightSafety International Inc - Strategy, SWOT and Corporate Finance Report Summary FlightSafety International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Merus NV (MRUS):企業の財務・戦略的SWOT分析
    Summary Merus NV (Merus) is a clinical-stage immuno-oncology company that discovers and develops human bispecific antibody therapeutics for the treatment of cancer. The company’s pipeline antibody candidates are intended for the treatment of breast cancer, ovarian cancer, colorectal cancer, acute my …
  • Homeland Energy Solutions, LLC:企業の戦略的SWOT分析
    Homeland Energy Solutions, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Kalle GmbH:企業の戦略的SWOT分析
    Kalle GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • PLC SPA (IIN):電力:M&Aディール及び事業提携情報
    Summary PLC SPA (PLC Group) formerly Industria e Innovazione S.p.A, is a provider of design, installation, and maintenance services for electrical infrastructures and renewable energy plants. The company’s service offerings include engineering, procurement, and construction (EPC); manufacturing and …
  • Jun Yang Financial Holdings Ltd:企業のM&A・事業提携・投資動向
    Jun Yang Financial Holdings Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Jun Yang Financial Holdings Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Foundation Medicine Inc (FMI):企業の財務・戦略的SWOT分析
    Summary Foundation Medicine Inc (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd, is a molecular information products provider. The company provides molecular information and cancer research programs. It offers clinical products such as FoundationOne for solid tumors and FoundationOne …
  • Myriad Genetics Inc (MYGN):医療機器:M&Aディール及び事業提携情報
    Summary Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. The company’s product portfolio includes molecular diagnostic testing products that analyze genes, t …
  • Suzuki Motor Corp (7269):企業の財務・戦略的SWOT分析
    Suzuki Motor Corp (7269) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sempra Energy (SRE):企業の財務・戦略的SWOT分析
    Sempra Energy (SRE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Thoresen Thai Agencies Public Company Limited:企業の戦略・SWOT・財務情報
    Thoresen Thai Agencies Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Thoresen Thai Agencies Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆